SEC Form 4/A · accession 0001209191-19-006549
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Paul Streck
Officer — Chief Medical Officer
Period of report
Jan 21, 2019
Accepted (ET)
Feb 1, 2019 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $13.41 | Jan 21, 2019 | A | 250,000 | A | — | Jan 20, 2029 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The exercise price was incorrectly entered in the Reporting Person's original Form 4.
- F2The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of January 21, 2019 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.